Tailored Prediabetes Treatment May Better Prevent Type 2 Diabetes

A one-size-fits-all attack to prediabetes curen whitethorn miss nan opportunity to instrumentality an early, much intensive, tailored prevention attack for those pinch nan highest consequence of processing Type 2 diabetes, according to preliminary investigation presented astatine nan American Heart Association's EPI|Lifestyle Scientific Sessions 2026. The gathering is successful Boston, March 17-20, 2026, and offers nan latest subject connected epidemiological subject connected prevention, manner and cardiometabolic health.

Diagnosis of Type 2 glucosuria and prediabetes are connected nan emergence successful adults 40 years aged and younger. Complications from Type 2 glucosuria see bosom disease, kidney illness and stroke, and it tin besides harm nerves successful nan brain, eyes and feet.

We cognize that arsenic a whole, group pinch prediabetes are astatine higher consequence for progression to Type 2 glucosuria and its complications. The U.S. Food and Drug Administration (FDA) has approved curen pinch nan caller weight-loss medications, called GLP-1 Receptor Agonists (GLP-1RA), for prime patients who meet definite criteria. We utilized these existing criteria to estimate nan consequence of processing Type 2 glucosuria successful young adults pinch glucose levels successful nan prediabetes range."

Mary Rooney, Ph.D., M.P.H., lead writer of nan study and adjunct investigation professor, section of epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore

Some GLP-1 RA medications are FDA-approved for group pinch Type 2 glucosuria and others to thief facilitate weight nonaccomplishment erstwhile fare and workout person not been effective. The eligibility criteria for prescribing GLP-1 RA medications for weight nonaccomplishment see obesity (body wide scale of 30 kg/m2 or higher), aliases overweight (body wide scale of 27 kg/m2) positive astatine slightest 1 related condition, specified arsenic precocious humor unit aliases precocious cholesterol. GLP-1 RA medications are not FDA-approved for nan prevention of Type 2 diabetes successful group pinch prediabetes.

For their analysis, investigators estimated nan 5-year consequence of progression from prediabetes to Type 2 glucosuria successful 662 young adults. Participants were followed for an mean of 7 years done 1 of 3 U.S.-based studies focused connected young big wellness and bosom illness risk.

The study found:

• The 5-year consequence of progression from prediabetes to Type 2 glucosuria was 7.5% overall.
• The consequence accrued to 10.9% for individuals who met nan criteria for curen pinch a GLP-1RA medicine for weight loss.
• In addition, nan 5-year consequence grew to 15.1% for those pinch higher levels of fasting glucose (110-125 mg/dL), and 24.8% for those pinch a higher fasting glucose and who met nan criteria for curen pinch a GLP-1 RA medication.

"Current approaches to Type 2 glucosuria prevention are 'one-size-fits-all.' Our results awesome that immoderate group pinch prediabetes person a higher consequence of progressing to Type 2 diabetes. These are nan patients who whitethorn use from much targeted, intensive curen than others," said Rooney.

According to the American Heart Association, manner changes, specified arsenic losing weight, eating patient and engaging successful regular, mean beingness activity, whitethorn trim nan progression of prediabetes to Type 2 diabetes, thief negociate Type 2 glucosuria and mitigate different consequence factors for illustration precocious humor pressure, arsenic good arsenic bosom attacks and stroke.

The study besides raises nan anticipation that GLP-1 RA medications mightiness beryllium beneficial to forestall progression to Type 2 glucosuria successful group pinch prediabetes who meet nan BMI measures for overweight aliases obesity and different weight-related wellness conditions.

"However, nan cost-effectiveness of GLP-1 RA medications for Type 2 glucosuria prevention, peculiarly successful subgroups pinch nan highest consequence for Type 2 diabetes, is not yet known," said Rooney.

"Different groups of group pinch Type 2 glucosuria whitethorn request different prevention strategies based connected their level of risk," said Joshua J. Joseph, M.D., M.P.H., FAHA, ASCI, an American Heart Association unpaid master and chair of nan Lifestyle Diabetes Committee for nan Association's Council connected Lifestyle and Cardiometabolic Health. "A adjacent measurement would beryllium to study a larger and much divers group of group truthful we tin amended understand really factors for illustration wherever personification lives, specified arsenic a agrarian aliases municipality setting, their inheritance and their organization power risk. These findings support nan thought of acting early, earlier Type 2 glucosuria and related bosom aliases kidney conditions go much serious, utilizing patient manner changes and, erstwhile needed, medications to little risk, accordant pinch nan cardiovascular-kidney-metabolic syndrome framework, which prioritizes early intervention." Joseph, who was not progressive successful this study, is an subordinate professor of soul medicine and nan endowed professor for investigation successful soul medicine at The Ohio State University Wexner Medical Center successful Columbus, Ohio.

Study details, inheritance aliases design: 

• The study included 662 young adults from 3 studies successful nan U.S.: nan Hispanic Community Health Study/Study of Latinos, nan Coronary Artery Risk Development successful Young Adults study and nan Framingham Heart Study Third Generation.
• Participants included adults ages 18-40 (mean property of 32 years) pinch prediabetes. 33% of each participants were women; 47% self-identified arsenic Hispanic/Latino, 45% self-identified arsenic non-Hispanic White and 7% self-identified arsenic non-Hispanic Black.
• Health information, including fasting glucose levels, weight and assemblage wide index, lipid levels and humor pressure, was measured during study visits betwixt 1985 and 2011, each anterior to nan first FDA support of GLP-1 RA medications for weight loss. 
• During a median follow-up play of astir 7 years, researchers analyzed really nan various consequence factors influenced nan 5-year consequence of progressing from prediabetes to Type 2 diabetes. 

The study's findings are constricted because participants' hemoglobin A1c humor tests, which measurement humor sweetener levels complete nan past 2-3 months, were not available. Hemoglobin A1c tin besides beryllium utilized to specify prediabetes. Only fasting glucose tests were included successful nan analysis.